期刊文献+

miR-210在不同病理分级的脑胶质瘤中的表达差异及对肿瘤细胞的作用 被引量:3

Analysis of the mechanism of miR-210 in the pathogenesis of nervous system tumors
下载PDF
导出
摘要 目的:探讨microRNA-210(miR-210)在脑胶质瘤中的表达,分析其对脑胶质瘤细胞凋亡和侵袭能力的影响。方法:选取2015年3月至2019年4月在我院治疗的56例原发性胶质瘤患者为肿瘤组,同时选取因颅脑损伤行颅内减压和癫痫手术但脑组织正常的23例患者为对照组,取患者少量脑组织,采用实时定量PCR检测miR-210表达。收集肿瘤组患者病理资料,分析不同病理特征患者的miR-210表达差异。对提取的部分胶质瘤细胞,根据是否做miR-210抑制剂转染分为转染和未转染miR-210抑制剂两组,采用流式细胞仪和Transwell法检测两组的胶质瘤细胞凋亡及侵袭能力的变化。结果:肿瘤组的miR-210相对表达量明显高于对照组(P<0.01)。WHO不同分级患者的胶质瘤组织中miR-210的表达比较有统计学意义(P<0.01),其中Ⅳ级患者最高、Ⅰ级患者最低。转染和未转染miR-210抑制剂组的胶质瘤细胞凋亡率比较差异无统计学意义(P>0.05);转染miR-210抑制剂组穿膜细胞数明显低于未转染miR-210抑制剂组(P<0.01)。结论:脑胶质瘤中miR-210呈高表达,其表达量与病理分级升高呈正相关,可促进脑胶质瘤细胞侵袭能力。 Objective:To investigate the expression of microRNA-210(miR-210)in glioma and analyze its effect on apoptosis and invasion of glioma cells.Methods:Fifty-six patients with primary glioma treated in our hospital from March 2015 to April 2019 were selected as the tumor group.At the same time,23 patients with normal brain tissue who underwent intracranial decompression and epilepsy due to craniocerebral injury were selected as the control group.Brain tissue was taken from patients,and the expression of microRNA-210 was detected by real-time quantitative PCR.The pathological data of the patients in the tumor group were collected and the expression of microRNA-210 in patients with different pathological characteristics was analyzed.Some glioma cells were divided into two groups according to whether or not they were transfected with the inhibitor of microRNA-210:Transfection group and non-transfection group.Flow cytometry and Transwell method were used to detect the apoptotic and invasive ability of glioma cells in the two groups.Results:The relative expression of microRNA-210 in the tumor group was significantly higher than that in the control group(P<0.01).The expression of microRNA-210 in glioma tissues of patients with different WHO grades had statistical significance(P<0.01),among which the highest level was in grade IV patients and the lowest level was in grade I patients.There was no significant difference in apoptotic rate of glioma cells between transfected and non-transfected group(P>0.05).The number of migrating cells in the transfected group was significantly lower than that in the non-transfected group(P<0.01).Conclusion:The expression of microRNA-210 is high in glioma,and its expression is positively correlated with the increase of pathological grade,which can promote the invasive ability of glioma cells.
作者 杜丽 付勇 杨江河 王强 Du Li;Fu Yong;Yang Jianghe;Wang Qiang(Department of Laboratory Pathology,Armed Police Corps General Hospital,Xinjiang Urumqi 830063,China;Department of Pathology;Department of Neurosurgery,General Hospital of Xinjiang Military Region,Xinjiang Urumqi 830000,China;Department of Anatomy,Gansu College of Traditional Chinese Medicine,Gansu Lanzhou 730000,China)
出处 《现代肿瘤医学》 CAS 2020年第8期1276-1280,共5页 Journal of Modern Oncology
基金 甘肃省自然科学基金项目(编号:16PRJ2A063)。
关键词 脑胶质瘤 MIR-210 侵袭能力 brain glioma miR-210 invasive ability
  • 相关文献

参考文献11

二级参考文献117

  • 1朱宝英,黄静,王永林,方翼.P-糖蛋白及肿瘤多药耐药的逆转[J].中国药房,2011,22(6):550-552. 被引量:25
  • 2曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
  • 3纪宇明,辛玲,杨国宽.莫替唑胺与尼莫司丁辅助治疗恶性脑胶质瘤的疗效对比[J].中华肿瘤防治杂志,2007,14(13):1021-1022. 被引量:16
  • 4Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system [ J ]. Aeta Neuropathol, 2007, 114(2) : 97 -109.
  • 5Shu HK, Wen PY, Olson JJ, et al. Exciting new advances in neuro- oncology: the avenue to a cure for malignant gliuma[J]. CA Cancer J Clin, 2010, 60(3) : 166 -193.
  • 6Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[ J ]. N Engl J Med, 2005, 352(10) : 987 -996.
  • 7Barrel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2) : 281 -297.
  • 8Xiao B, Wang Y, Li W, et al. Plasma microRNA signature as a non- invasive biomarker for acute graft-versus-host disease [ J ]. Blood, 2013, 122(19) : 3365 -3375.
  • 9Xiao ZG, Deng ZS, Zhang YD, et al. Clinical significance of microRNA-93 downregnlation in human colon cancer [ J ]. Eur J Gastroenterol Hepatol, 2013, 25 (3) : 296 - 301.
  • 10Gupta S, Read DE, Deepti A, et al. Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis [J/OA]. Cell Death Dis, 2012, 3: e333.

共引文献60

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部